3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
59
Breast Neoplasms
55
Ovarian Neoplasms
35
Triple Negative Breast Neoplasms
29
Lung Neoplasms
25
Fallopian Tube Neoplasms
24
Endometrial Neoplasms
24
Neoplasm Metastasis
22
Parkinson Disease 4, Autosomal Dominant Lewy Body
19
Squamous Cell Carcinoma of Head and Neck
18
Neoplasms
15
Esophageal Neoplasms
13
Esophageal Squamous Cell Carcinoma
12
Head and Neck Neoplasms
10
Carcinoma, Ovarian Epithelial
10
Stomach Neoplasms
9
Carcinoma
9
Colorectal Neoplasms
8
Adenocarcinoma Of Esophagus
7
Adenocarcinoma
7
Peritoneal Neoplasms
6
Uterine Cervical Neoplasms
5
Melanoma
5
Small Cell Lung Carcinoma
4
Oropharyngeal Neoplasms
4
Cholangiocarcinoma
4
Carcinoma, Transitional Cell
4
Urinary Bladder Neoplasms
3
Respiratory Tract Neoplasms
3
Recurrence
3
Interventions
Bevacizumab
3
contrast agent BR1
2
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Microbubbles
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
Biopsy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Nerve Tissue
×
Paclitaxel
×
90 days
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts